Intrazolina

Cefazolin, the active ingredient in Intrazolina, is a first‑generation cephalosporin presented as an injectable solution for intramuscular and intravenous use. It treats a range of bacterial infections, including skin, urinary, respiratory, bone and joint infections, and is commonly employed for surgical prophylaxis in adult patients.

GNH USA supplies Intrazolina as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals worldwide. The company adheres to stringent quality standards and provides regulatory‑approved batches to healthcare facilities across multiple continents.

Cefazolin is a first‑generation cephalosporin used to manage bacterial infections affecting various organ systems.

- Skin and soft‑tissue infections: effective for cellulitis, wound infections, and erysipelas, reducing bacterial load and promoting healing. - Urinary tract infections: treats uncomplicated and complicated UTIs caused by susceptible Gram‑negative organisms. - Respiratory tract infections: used for pneumonia and bronchitis caused by susceptible strains. - Surgical prophylaxis: administered pre‑operatively to prevent postoperative wound infections. - Bone and joint infections: employed in osteomyelitis and septic arthritis to eradicate causative bacteria.

Cefazolin may cause a range of adverse reactions, from mild to severe.

Common Side Effects: - Injection site pain: localized discomfort at the IM or IV site. - Rash: mild skin erythema or pruritus. - Nausea: transient gastrointestinal upset. - Diarrhea: loose stools, usually self‑limiting.

Serious or Rare Side Effects: - Anaphylaxis: severe allergic reaction requiring immediate medical attention. - Stevens‑Johnson syndrome: rare severe skin eruption. - Clostridioides difficile‑associated diarrhea: colitis that may be life‑threatening.

When using cefazolin, several precautionary measures should be observed to ensure safety. - Renal function: adjust dosing in patients with impaired renal clearance. - Allergy history: avoid in individuals with known cephalosporin or penicillin hypersensitivity. - Pregnancy: category B; use only if clinical benefit outweighs potential risk. - Concomitant antibiotics: monitor for antagonistic effects when combined with bacteriostatic agents. - Neonates and infants: dose carefully, considering immature renal function. - Store below 25°C: keep in original packaging, protect from moisture and light.

Cefazolin can interact with other medicines, altering efficacy or safety.

Major Interactions (Avoid): - Aminoglycosides: combined use may increase risk of nephrotoxicity. - Loop diuretics: may potentiate ototoxicity when nephrotoxic agents are co‑administered. - Warfarin: cefazolin may enhance anticoagulant effect, increasing bleeding risk.

Moderate Interactions (Monitor Closely): - Probenecid: reduces renal excretion of cefazolin, potentially raising plasma levels. - Oral contraceptives: may diminish hormonal efficacy; advise additional contraceptive measures.